Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of intranasal (R)-ketamine hydrochloride in depressed patients with acute suicidal ideation or behavior
CTR20251359Phase 2Completed
- Sponsor
- Sichuan Prit Pharmaceutical
- Start
- May 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of r-ketamine in major depressive disorder (MDD), sponsored by Sichuan Prit Pharmaceutical. Started May 2025; status: completed.
02
Drugs
r-ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20251359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251359.